These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2954584)

  • 1. Reconstitution of affinity-purified dopamine D2 receptor binding activities by specific lipids.
    Srivastava LK; Kazmi SM; Blume AJ; Mishra RK
    Biochim Biophys Acta; 1987 Jun; 900(2):175-82. PubMed ID: 2954584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
    Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of bovine striatal dopamine D-2 receptor by affinity chromatography.
    Ramwani J; Mishra RK
    J Biol Chem; 1986 Jul; 261(19):8894-8. PubMed ID: 2941422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of the D-2 dopamine receptor from bovine striatum.
    Elazar Z; Kanety H; David C; Fuchs S
    Biochem Biophys Res Commun; 1988 Oct; 156(1):602-9. PubMed ID: 2972288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
    Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK
    J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK; Ross GM; Bajwa SB; Mishra RK
    Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity chromatography of the anterior pituitary D2-dopamine receptor.
    Senogles SE; Amlaiky N; Johnson AL; Caron MG
    Biochemistry; 1986 Feb; 25(4):749-53. PubMed ID: 2938619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the use of a novel affinity matrix, sepharose amine-succinyl-amine haloperidol hemisuccinate, ASA-HHS, for purification of canine dopamine (D2) receptor.
    Antonian L; Antonian E; Murphy RB; Schuster DI
    Life Sci; 1986 May; 38(20):1847-58. PubMed ID: 3010025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny.
    Saleh MI; Kostrzewa RM
    Peptides; 1989; 10(1):35-9. PubMed ID: 2568624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone.
    Niznik HB; Grigoriadis DE; Seeman P
    FEBS Lett; 1986 Dec; 209(1):71-6. PubMed ID: 2948835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization and reconstitution of the D-1 dopamine receptor: potentiation of the agonist high-affinity state of the receptor.
    Sidhu A
    Biochemistry; 1988 Nov; 27(24):8768-76. PubMed ID: 2977287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanadate inhibits agonist binding to D2 dopamine receptor.
    Elazar Z; Fuchs S
    J Mol Neurosci; 1991; 3(1):1-6. PubMed ID: 1679343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of phospholipids on the specific binding of [3H]spiroperidol to the cholate extract of rat brain synaptic membranes.
    Moroi K; Hsu LL
    Int J Biochem; 1985; 17(5):637-44. PubMed ID: 4029482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization of D2 dopamine receptor coupled to guanine nucleotide regulatory protein from bovine striatum.
    Kuno T; Saijoh K; Tanaka C
    J Neurochem; 1983 Sep; 41(3):841-7. PubMed ID: 6308173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.
    Srivastava LK; Mishra RK
    Biochem Int; 1990; 21(4):705-14. PubMed ID: 2241996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel affinity purification of D-1 dopamine receptors from rat striatum.
    Sidhu A
    J Biol Chem; 1990 Jun; 265(17):10065-72. PubMed ID: 2141020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of binding sites for [3H]spiroperidol.
    Luedtke RR; Molinoff PB
    Biochem Pharmacol; 1987 Oct; 36(19):3255-64. PubMed ID: 2959288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.